Deadline for manuscript submissions: 31 May 2021Print Special Issue Flyer (8)
Assistant professor and attending physician, Department of Emergency Medicine, Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Taoyuan City, Taiwan
Interests: Cardiology, Critical care medicine, Hyperbaric oxygen medicine, Medical education
Ischemic heart disease is one of the most important topics of emergency and critical care medicine. The diagnosis of myocardial infarction (MI) is confirmed when there are typical symptoms with suggestive electrocardiographic (ECG) changes, a rise of troponin, or imaging evidence of new regional wall motion abnormality. Early recognition of acute coronary syndrome (ACS) and immediate treatment including medication and reperfusion is essential to the prognosis of the patients. The advance in treatment, either new medication like antiplatelet drug or technique of primary coronary intervention, improves the prognosis of patients with ACS and MI.
Nevertheless, there are still many challenges in this field. The interpretation of ECG change depends on physicians and could have different interpretation. Incorrect ECG reading may delay the diagnosis and treatment, especially in ST elevation MI (STEMI), and causes worse prognosis. Besides, the elevation of cardiac enzyme could occur in not only myocardial infraction but also other situations, so the diagnosis of MI could not depend on the rise of cardiac enzyme. Although medications like new antiplatelet and new anticoagulant drugs are developed and have better treatment effect, the complications of these drugs bring new challenges. Sustained research and continued education of ACS and MI are important and necessary.
The aim of this special issue is to collect new research of diagnosis, treatment, and prognosis of myocardial infarction from worldwide. Studies working on the diagnosis or exclusion of MI are useful for emergency physicians to decide disposition of patients with chest pain. Treatment with different medication and related complications are important to help physicians choose medication and decide the treatment plan. We expect this special issue could help readers to review and apply new diagnosis strategy and have different treatment options. We also aim to help physicians learn up-to-date knowledge and realize the direction of research of this field. Clinical research and review article on diagnosis, treatment, prognosis of myocardial infarction and ACS are welcomed. We are also interested in case reports or case series of MI/ACS with educational meanings. We hope this special issue can help health providers learn the most advanced knowledge and improve their treatment of myocardial infarction.
Myocardial infarction, Acute coronary syndrome, ST-elevation myocardial infarction, Non-ST elevation myocardial infarction, Unstable angina, Primary coronary intervention
Manuscripts should be submitted online by submit system. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Original articles, case reports or comprehensive reviews are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website. Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a double-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Signa Viate is an international peer-reviewed open access journal published by MRE Press. As of January 2021, Signa Vitae will change to a bimonthly journal. Please visit the Instructions for Authors page before submitting a manuscript.The Article Processing Charge (APC) for publication in this open access journal is $1200. We normally offer a discount greater than 30% to all contributors invited by the Editor-in-Chief, Guest Editor (GE) and Editorial board member. Submitted papers should be well formatted and use good English.
Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,200 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.
Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.
Chemical Abstracts Service Source Index The CAS Source Index (CASSI) Search Tool is an online resource that can quickly identify or confirm journal titles and abbreviations for publications indexed by CAS since 1907, including serial and non-serial scientific and technical publications.
IndexCopernicus The Index Copernicus International (ICI) Journals database’s is an international indexation database of scientific journals. It covered international scientific journals which divided into general information, contents of individual issues, detailed bibliography (references) sections for every publication, as well as full texts of publications in the form of attached files (optional). For now, there are more than 58,000 scientific journals registered at ICI.
Geneva Foundation for Medical Education and Research The Geneva Foundation for Medical Education and Research (GFMER) is a non-profit organization established in 2002 and it works in close collaboration with the World Health Organization (WHO). The overall objectives of the Foundation are to promote and develop health education and research programs.
Scopus: CiteScore 0.5(2019) Scopus is Elsevier's abstract and citation database launched in 2004. Scopus covers nearly 36,377 titles (22,794 active titles and 13,583 Inactive titles) from approximately 11,678 publishers, of which 34,346 are peer-reviewed journals in top-level subject fields: life sciences, social sciences, physical sciences and health sciences.
Embase Embase (often styled EMBASE for Excerpta Medica dataBASE), produced by Elsevier, is a biomedical and pharmacological database of published literature designed to support information managers and pharmacovigilance in complying with the regulatory requirements of a licensed drug.